COMPASS Pathways plc
Healthcare · Medical Care Facilities
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
61
Total Trades
61
Buy Orders
3.14M shares
0
Sell Orders
0.00M shares
+3.14M
Net Position
| Date | Type | Fund | Shares | % of Fund |
|---|---|---|---|---|
| Mar 31 | Buy | ARKG | 44,714 | 0.025% |
| Mar 30 | Buy | ARKG | 69,571 | 0.038% |
| Mar 29 | Buy | ARKG | 14,835 | 0.009% |
| Mar 3 | Buy | ARKG | 33,613 | 0.015% |
| Mar 2 | Buy | ARKG | 13,592 | 0.006% |
| Mar 1 | Buy | ARKG | 55,422 | 0.022% |
| Feb 28 | Buy | ARKG | 26,577 | 0.011% |
| Feb 27 | Buy | ARKG | 36,885 | 0.016% |
| Feb 24 | Buy | ARKG | 18,914 | 0.008% |
| Feb 23 | Buy | ARKG | 6,990 | 0.003% |
| Feb 8 | Buy | ARKG | 12,061 | 0.005% |
| Feb 7 | Buy | ARKG | 7,233 | 0.003% |
| Feb 3 | Buy | ARKG | 16,979 | 0.007% |
| Feb 2 | Buy | ARKG | 19,868 | 0.009% |
| Feb 1 | Buy | ARKG | 25,869 | 0.012% |
| Jan 31 | Buy | ARKG | 26,530 | 0.012% |
| Jan 30 | Buy | ARKG | 116,034 | 0.053% |
| Jan 27 | Buy | ARKG | 103,589 | 0.050% |
| Jan 26 | Buy | ARKG | 120,303 | 0.058% |
| Jan 25 | Buy | ARKG | 15,288 | 0.007% |
| Jan 24 | Buy | ARKG | 14,345 | 0.007% |
| Jan 23 | Buy | ARKG | 20,404 | 0.009% |
| Jan 20 | Buy | ARKG | 39,497 | 0.018% |
| Jan 19 | Buy | ARKG | 158,195 | 0.068% |
| Jan 18 | Buy | ARKG | 156,657 | 0.068% |
| Jan 17 | Buy | ARKG | 22,652 | 0.010% |
| Jan 13 | Buy | ARKG | 29,740 | 0.013% |
| Jan 12 | Buy | ARKG | 25,669 | 0.010% |
| Jan 11 | Buy | ARKG | 33,058 | 0.013% |
| Jan 10 | Buy | ARKG | 14,981 | 0.006% |
| Jan 9 | Buy | ARKG | 34,885 | 0.014% |
| Date | Type | Fund | Shares | % of Fund |
|---|---|---|---|---|
| Dec 15 | Buy | ARKG | 7,788 | 0.004% |
| Dec 14 | Buy | ARKG | 18,408 | 0.009% |
| Dec 13 | Buy | ARKG | 59,403 | 0.029% |
| Dec 12 | Buy | ARKG | 929 | 0.000% |
| Dec 9 | Buy | ARKG | 1,797 | 0.001% |
| Dec 8 | Buy | ARKG | 1,630 | 0.001% |
| Nov 2 | Buy | ARKG | 138,640 | 0.060% |
| Oct 31 | Buy | ARKG | 20,102 | 0.009% |
| Oct 27 | Buy | ARKG | 5,000 | 0.002% |
| Oct 13 | Buy | ARKG | 48,002 | 0.021% |
| Oct 12 | Buy | ARKG | 306,547 | 0.146% |
| Oct 11 | Buy | ARKG | 205,669 | 0.103% |
| Oct 10 | Buy | ARKG | 49,792 | 0.024% |
| Sep 2 | Buy | ARKG | 38,537 | 0.023% |
| Sep 1 | Buy | ARKG | 73,166 | 0.044% |
| Aug 30 | Buy | ARKG | 96,943 | 0.059% |
| Aug 29 | Buy | ARKG | 67,000 | 0.043% |
| Aug 26 | Buy | ARKG | 20,177 | 0.012% |
| Aug 23 | Buy | ARKG | 56,139 | 0.035% |
| Aug 22 | Buy | ARKG | 45,457 | 0.028% |